Drug profile · INN
ketamine hydrochloride
KETAMINE HCL
ketamine hydrochloride (KETAMINE HCL) is a glutamate [nmda] receptor negative allosteric modulator. Route of administration: injection. Current US regulatory status: approved.
Drug details — ketamine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 7
- Data quality
- 0.84
Quick answer
ketamine hydrochloride (KETAMINE HCL) is a glutamate [nmda] receptor negative allosteric modulator. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Glutamate [NMDA] receptor negative allosteric modulator
Primary target: Glutamate [NMDA] receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is ketamine hydrochloride?
ketamine hydrochloride (KETAMINE HCL) is a glutamate [nmda] receptor negative allosteric modulator. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ketamine hydrochloride?
KETAMINE HCL is a marketed brand name for ketamine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ketamine hydrochloride?
ketamine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.